Impact of high cholesterol in a Parkinson's disease model: Prevention of lysosomal leakage versus stimulation of α-synuclein aggregation.
about
Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.Intracellular Cholesterol Trafficking and Impact in Neurodegeneration.The importance of cholesterol in Parkinson's disease.Is Parkinson's disease a lysosomal disorder?Lipid Extraction by α-Synuclein Generates Semi-Transmembrane Defects and Lipoprotein Nanoparticles
P2860
Impact of high cholesterol in a Parkinson's disease model: Prevention of lysosomal leakage versus stimulation of α-synuclein aggregation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Impact of high cholesterol in ...... on of α-synuclein aggregation.
@en
type
label
Impact of high cholesterol in ...... on of α-synuclein aggregation.
@en
prefLabel
Impact of high cholesterol in ...... on of α-synuclein aggregation.
@en
P2093
P1476
Impact of high cholesterol in ...... ion of α-synuclein aggregation
@en
P2093
Ana Maria Villamil Giraldo
Karin Öllinger
Per Bornefall
Sangeeta Nath
P304
P356
10.1016/J.EJCB.2017.01.002
P50
P577
2017-01-16T00:00:00Z